Activating transcription factor 3 modulates protein kinase C epsilon activation in diabetic peripheral neuropathy

Ying-Shuang Chang; Hung-Wei Kan; Yu-Lin Hsieh

doi:10.2147/JPR.S186699

Activating transcription factor 3 modulates protein kinase C epsilon activation in diabetic peripheral neuropathy

J Pain Res. 2019 Jan 14:12:317-326. doi: 10.2147/JPR.S186699. eCollection 2019.

Authors

Ying-Shuang Chang¹, Hung-Wei Kan², Yu-Lin Hsieh^{1

3}

Affiliations

¹ Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan, ylhsieh@kmu.edu.tw.
² Department of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
³ Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan, ylhsieh@kmu.edu.tw.

Abstract

Background: Skin denervation that develops in patients with diabetes mellitus as a neuropathic manifestation is known as diabetic peripheral neuropathy (DPN). Skin denervation is parallel to neuronal injuries that alter intracellular signaling. To date, the correlation between nerve injury and the activation of intracellular responses to neuropathic manifestations has not been elucidated; specifically, whether activating transcription factor 3 (ATF3) is responsible for neuronal injury and a critical molecule that modulates the activation of intracellular protein kinase C epsilon (p-PKCε) and pain development in DPN is a crucial question.

Methods: To address, ATF3 knockout (atf3 ^-/- group, C57/B6 genetic background) and wild-type mice (atf3^+/+ group) received a single dose of streptozotocin (200 mg/kg) to generate a mouse model of DPN.

Results: Both atf3^+/+ and atf3 ^-/- mice exhibited hyperglycemia and the same pathology of skin denervation at posttreatment month 2, but only atf3^+/+ mice developed thermal hyperalgesia (P<0.001) and mechanical allodynia (P=0.002). The atf3^+/+ group, but not the atf3 ^-/- group, had preferential ATF3 upregulation on p-PKCε(+) neurons with a ratio of 37.7%±6.1% in p-PKCε(+):ATF3(+) neurons (P<0.001). In addition, B-cell lymphoma-extra large (Bcl-_XL), an antiapoptotic Bcl2 family protein, exhibited parallel patterns to p-PKCε (ie, Bcl-_XL upregulation was reversed in atf3 ^-/- mice). These two molecules were colocalized and increased by approximately two-fold in the atf3^+/+ group compared with the atf3 ^-/- group (30.0%±3.4% vs 13.7% ± 6.2%, P=0.003). Furthermore, linear analysis results showed that the densities of p-PKCε and Bcl-_XL had a reverse linear relationship with the degrees of thermal hyperalgesia and mechanical allodynia.

Conclusion: Collectively, this report suggested that ATF3 is a critical upstream molecule that modulates p-PKCε and Bcl-_XL expression, which consequently mediated the development of neuropathic manifestation in DPN.

Keywords: B-cell lymphoma-extra large; Bcl-XL; PKCε; activating transcription factor 3; diabetic peripheral neuropathy; neuropathic pain; protein kinase C epsilon.